All Stories

  1. Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants – a case series

    Article • Neuropsychiatric Disease and Treatment, December 2011, Taylor & Francis

    Dr Mike Briley, Professor Eiji Kirino

  2. The noradrenergic symptom cluster: clinical expression and neuropharmacology

    Article • Neuropsychiatric Disease and Treatment, June 2011, Taylor & Francis

    Dr Mike Briley

  3. Choking risk among psychiatric inpatients

    Article • Neuropsychiatric Disease and Treatment, June 2011, Taylor & Francis

    Dr Mike Briley

  4. Noradrenergic symptom cluster in depression

    Article • Neuropsychiatric Disease and Treatment, May 2011, Taylor & Francis

    Dr Mike Briley

  5. The increasing burden of depression

    Article • Neuropsychiatric Disease and Treatment, May 2011, Taylor & Francis

    Dr Mike Briley

  6. The importance of norepinephrine in depression

    Article • Neuropsychiatric Disease and Treatment, May 2011, Taylor & Francis

    Dr Mike Briley

  7. Improvement of the noradrenergic symptom cluster following treatment with milnacipran

    Article • Neuropsychiatric Disease and Treatment, May 2011, Taylor & Francis

    Dr Mike Briley

  8. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities

    Article • Neuropsychiatric Disease and Treatment, October 2010, Taylor & Francis

    Dr Mike Briley

  9. Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors

    Article • Neuropsychiatric Disease and Treatment, September 2010, Taylor & Francis

    Dr Mike Briley

  10. Milnacipran: recent findings in depression

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  11. Editorial Foreword - Milnacipran: recent findings in depression

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  12. Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  13. Treatment of patients with comorbid depression and diabetes with metformin and milnacipran

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  14. Antidepressant therapy with milnacipran and venlafaxine

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  15. Milnacipran: a unique antidepressant?

    Article • Neuropsychiatric Disease and Treatment, August 2010, Taylor & Francis

    Dr Mike Briley

  16. Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study

    Article • Neuropsychiatric Disease and Treatment, June 2010, Taylor & Francis

    Dr Mike Briley, Takahiko Nagamine

  17. Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study

    Article • Neuropsychiatric Disease and Treatment, March 2010, Taylor & Francis

    Dr Mike Briley

  18. SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

    Article • CNS Spectrums, September 2005, Cambridge University Press

    Dr Mike Briley